Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06065046 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 13, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Collaborators: 5 to 12v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 7 more changesShow less
    • Primary completion date: Jul 2025 to Jun 30, 2026
    • Study completion date: Dec 2025 to Dec 31, 2026
    • Start date changed from estimate of Oct 2023 to Nov 24, 2023
    • Secondary endpoints: 8 to 7
    • Study description expanded, about 8 words
    • Site details revised
    • Collaborators expanded, about 29 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the present study is to study the effect of baricitinib administration on outcome of participants with moderate and severe traumatic intracerebral hemorrhage/contusions. A multi-center randomized control trial will be conducted. Participants with a radiological diagnosis of traumatic intracerebral hemorrhage/contusions and an initial GCS score of 5-12 will be screened and enrolled in the first 24 hours after traumatic brain injury.
Trial Details
NCT Number NCT06065046
Lead Sponsor Tang-Du Hospital
Collaborators: Qianxian People's Hospital, Weinan Central Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, The First Hospital of Yulin, Xidian Group Hospital, Chongqing University Central Hospital & Chongqing Emergency Medical Center, The Peoples' Hospital of Jiaozuo City, First People's Hospital of Xianyang, 987th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Chongqing Hospital of PAP, Baoji Fengxiang District Hospital, GEM Flower Xian Changqing Staff Hospital
Conditions
(from sponsor)		 Traumatic Brain Injury
Related terms Brain Injuries, Traumatic, Cerebral Hemorrhage, Traumatic
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov